The Moving Average Convergence Divergence (MACD) for BMA turned positive on November 03, 2026. Looking at past instances where BMA's MACD turned positive, the stock continued to rise in 39 of 41 cases over the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BMA's RSI Oscillator exited the oversold zone, 22 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +2.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMA advanced for three days, in 235 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
BMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMA as a result. In 66 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for BMA entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BMA's P/B Ratio (0.001) is slightly lower than the industry average of (1.271). P/E Ratio (0.001) is within average values for comparable stocks, (13.500). Projected Growth (PEG Ratio) (0.520) is also within normal values, averaging (1.190). Dividend Yield (0.032) settles around the average of (0.036) among similar stocks. BMA's P/S Ratio (1.824) is slightly lower than the industry average of (3.738).
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. BMA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
BSAC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 25 of 30 cases where BSAC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BSAC's RSI Oscillator exited the oversold zone, 12 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 67 cases where BSAC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for BSAC just turned positive on November 03, 2026. Looking at past instances where BSAC's MACD turned positive, the stock continued to rise in 33 of 51 cases over the following month. The odds of a continued upward trend are 65%.
Following a +4.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where BSAC advanced for three days, in 239 of 349 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BSAC as a result. In 48 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 58%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BSAC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
The Aroon Indicator for BSAC entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BSAC's P/B Ratio (0.003) is slightly lower than the industry average of (1.271). P/E Ratio (0.013) is within average values for comparable stocks, (13.500). Projected Growth (PEG Ratio) (2.596) is also within normal values, averaging (1.190). BSAC's Dividend Yield (0.166) is considerably higher than the industry average of (0.036). P/S Ratio (5.236) is also within normal values, averaging (3.738).
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. BSAC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
BMA | BSAC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 70 | 74 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 15 Undervalued | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 2 | 2 | |
SMR RATING 1..100 | 1 | 1 | |
PRICE GROWTH RATING 1..100 | 76 | 56 | |
P/E GROWTH RATING 1..100 | 97 | 97 | |
SEASONALITY SCORE 1..100 | n/a | 7 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BSAC's Valuation (4) in the Regional Banks industry is in the same range as BMA (15). This means that BSAC’s stock grew similarly to BMA’s over the last 12 months.
BSAC's Profit vs Risk Rating (2) in the Regional Banks industry is in the same range as BMA (2). This means that BSAC’s stock grew similarly to BMA’s over the last 12 months.
BSAC's SMR Rating (1) in the Regional Banks industry is in the same range as BMA (1). This means that BSAC’s stock grew similarly to BMA’s over the last 12 months.
BSAC's Price Growth Rating (56) in the Regional Banks industry is in the same range as BMA (76). This means that BSAC’s stock grew similarly to BMA’s over the last 12 months.
BSAC's P/E Growth Rating (97) in the Regional Banks industry is in the same range as BMA (97). This means that BSAC’s stock grew similarly to BMA’s over the last 12 months.
| BMA | BSAC | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | 1 day ago 63% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 73% |
| Momentum ODDS (%) | 1 day ago 76% | 1 day ago 58% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 65% |
| TrendWeek ODDS (%) | 1 day ago 76% | 1 day ago 66% |
| TrendMonth ODDS (%) | 1 day ago 79% | 1 day ago 46% |
| Advances ODDS (%) | 15 days ago 80% | 1 day ago 68% |
| Declines ODDS (%) | 3 days ago 78% | 6 days ago 54% |
| BollingerBands ODDS (%) | 1 day ago 64% | 1 day ago 83% |
| Aroon ODDS (%) | 1 day ago 81% | 1 day ago 46% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BMA’s FA Score shows that 3 FA rating(s) are green while BSAC’s FA Score has 3 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BMA’s TA Score shows that 5 TA indicator(s) are bullish while BSAC’s TA Score has 5 bullish TA indicator(s).
BMA (@Regional Banks) experienced а -2.56% price change this week, while BSAC (@Regional Banks) price change was +0.22% for the same time period.
The average weekly price growth across all stocks in the @Regional Banks industry was -0.25%. For the same industry, the average monthly price growth was +0.62%, and the average quarterly price growth was +7.29%.
BMA is expected to report earnings on Nov 25, 2026.
BSAC is expected to report earnings on Jan 29, 2027.
Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.
A.I.dvisor indicates that over the last year, BMA has been closely correlated with GGAL. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if BMA jumps, then GGAL could also see price increases.
| Ticker / NAME | Correlation To BMA | 1D Price Change % | ||
|---|---|---|---|---|
| BMA | 100% | +1.97% | ||
| GGAL - BMA | 94% Closely correlated | N/A | ||
| BBAR - BMA | 91% Closely correlated | +0.62% | ||
| SUPV - BMA | 89% Closely correlated | -1.64% | ||
| BSAC - BMA | 50% Loosely correlated | +0.82% | ||
| NU - BMA | 50% Loosely correlated | -0.09% | ||
More | ||||
A.I.dvisor indicates that over the last year, BSAC has been closely correlated with BCH. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSAC jumps, then BCH could also see price increases.
| Ticker / NAME | Correlation To BSAC | 1D Price Change % | ||
|---|---|---|---|---|
| BSAC | 100% | +0.82% | ||
| BCH - BSAC | 87% Closely correlated | +0.03% | ||
| ITUB - BSAC | 65% Loosely correlated | -1.67% | ||
| INTR - BSAC | 61% Loosely correlated | -2.98% | ||
| DB - BSAC | 59% Loosely correlated | -0.18% | ||
| CIB - BSAC | 56% Loosely correlated | +0.74% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TUG | 44.95 | 0.28 | +0.63% |
| STF Tactical Growth ETF (TUG) | |||
| JOYT | 59.31 | 0.24 | +0.41% |
| JPMorgan Equity and Options Total Return ETF (JOYT) | |||
| JMSI | 48.65 | -0.13 | -0.28% |
| JPMorgan Sustainable Municipal Income ETF (JMSI) | |||
| IDEQ | 33.27 | -0.16 | -0.48% |
| Lazard Active ETF TR | |||
| NVOH | 22.64 | -0.15 | -0.66% |
| NOVO NORDISK A/S (B SHARES) ADRHEDGED | |||